~~<i id='8155D0F268'><strike id='8155D0F268'><tt id='8155D0F268'><pre id='8155D0F268'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

entertainment

author：hotspot 2025-08-26 23:44:37 - browse：89

Acadia Pharmaceuticals said Monday that its approved medicine called Nuplazid failed to improve the social and emotional symptoms of schizophrenia in a late-stage clinical trial.

The negative outcome of the Phase 3 study represents a setback in the company’s efforts to expand the use of Nuplazid into the treatment of schizophrenia. The medicine is currently approved to treat hallucinations and delusions associated with Parkinson’s disease psychosis.

“We are disappointed the trial did not meet its primary endpoint given the significant unmet need in patients with negative symptoms of schizophrenia,” said Acadia CEO Steve Davis, in a statement.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Meta looks to target Twitter with a rival app called Threads

explore

hotspot

Wikipedia

hotspot

entertainment

Wikipedia

Themedicalcommunitytodayfacesadeceptivelysimplequestion:Howquicklyshouldweactwhenachild’slifeisonthe

WSS

Bacterial infection may be ‘key event’ in endometriosis, study says

New case study details death in closely watched Alzhiemer's trial

Option Care buys Amedisys in $3.6 billion home care deal

Listen: PBM conflicts, RSV vaccines, & the future of flu season

Make 'food is medicine' a key part of White House nutrition meeting

Doctor appointment wait times are getting worse

knowledge

entertainment

explore

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Grail is spending more than ever lobbying Congress

Medicare details structure of new drug price negotiation program

Did the public have the right to know Arthur Ashe had AIDS?

At least 13 dead in Texas as scorching temps continue

Will the market for weight loss drugs really reach $100 billion?

Medical records are filled with copy

Make 'food is medicine' a key part of White House nutrition meeting

Peter Hotez and the public health issue of online harassment

BIO selects John Crowley as new CEO

hotspot

Cigna, Humana reportedly in talks to merge

UnitedHealth’s Optum accused of antitrust violations in California

Rep. Raul Ruiz on the physician shortage and more

Bacterial infection may be ‘key event’ in endometriosis, study says

A new study asks: Are we harming blood donors by taking blood?

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

Wikipedia

hotspot

entertainment

Wikipedia